Celularity (CELUW) Other Non Operating Income (2020 - 2025)
Celularity (CELUW) reported Other Non Operating Income of $62000.0 for Q4 2025, down 19.48% year-over-year from $77000.0 in Q4 2024, and up 110.0% quarter-over-quarter from -$620000.0 in Q3 2025.
Celularity (CELUW) Other Non Operating Income (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Other Non Operating Income data on file, last reported at $62000.0 in Q4 2025.
- Other Non Operating Income for Q4 2025 came in at $62000.0, down 19.48% year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.2 million (down 1982.78% YoY), and the FY2025 annual result was $262000.0, down 20.85% from the prior year.
- Other Non Operating Income improved to $62000.0 in Q4 2025 per CELUW's latest filing, from -$620000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $210000.0 in Q4 2022 and troughed at -$5.7 million in Q1 2025.
- A 5-year average of -$263157.9 and a median of $66000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income soared 2525.0% in 2022, then slumped 5314.55% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at $8000.0 in 2021, then soared by 2525.0% to $210000.0 in 2022, then plunged by 45.24% to $115000.0 in 2023, then tumbled by 33.04% to $77000.0 in 2024, then dropped by 19.48% to $62000.0 in 2025.
- Business Quant data shows CELUW's Other Non Operating Income at $62000.0 in Q4 2025, -$620000.0 in Q3 2025, and $62000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celularity | - | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | -620,000.00 |
| Jun 30, 2025 | 62,000.00 |
| Mar 31, 2025 | -5.74 Mn |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 110,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 66,000.00 |
| Dec 31, 2022 | 210,000.00 |
| Sep 30, 2022 | 108,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 55,000.00 |
| Jun 30, 2021 | 129,000.00 |
| Mar 31, 2021 | 140,000.00 |
| Dec 31, 2020 | 134,000.00 |